Clinical significance of serum glucose to lymphocyte ratio as a prognostic marker in peritoneal dialysis patients

References

• Li PK, Chow KM, VAN DE Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):1–10. doi: 10.1038/nrneph.2016.181.
   PubMed Web of Science ®Google Scholar
• Tien KJ, Lin ZZ, Chio CC, et al. Epidemiology and mortality of new-onset diabetes after dialysis: Taiwan national Cohort study. Diabetes Care. 2013;36(10):3027–3032. doi: 10.2337/dc12-2148.
   PubMed Web of Science ®Google Scholar
• Szeto CC, Chow KM, Kwan BC, et al. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis. 2007;49(4):524–532. doi: 10.1053/j.ajkd.2007.01.018.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu Y, Wang D, et al. Prognostic value of ­preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. Int J Clin Oncol. 2021;26(1):135–144. doi: 10.1007/s10147-020-01782-y.
   PubMed Web of Science ®Google Scholar
• Navarro J, Kang I, Hwang HK, et al. Glucose to lymphocyte ratio as a prognostic marker in patients with ­resected pT2 gallbladder cancer. J Surg Res. 2019;240:17–29. doi: 10.1016/j.jss.2019.02.043.
   PubMed Web of Science ®Google Scholar
• Cai S, Wang Q, Ma C, et al. Association between glucose-to-lymphocyte ratio and in-hospital mortality in intensive care patients with sepsis: a retrospective observational study based on medical information mart for intensive care IV. Front Med. 2022;9:922280. doi: 10.3389/fmed.2022.922280.
   Web of Science ®Google Scholar
• Hu T, Liu X, Liu Y. Usefulness of glucose to lymphocyte ratio to predict in-Hospital mortality in patients with AECOPD admitted to the intensive care unit. Copd. 2022;19(1):158–165. doi: 10.1080/15412555.2022.2052272.
   PubMedGoogle Scholar
• Zhong A, Cheng CS, Kai J, et al. Clinical significance of glucose to lymphocyte ratio (GLR) as a prognostic marker for patients with pancreatic cancer. Front Oncol. 2020;10:520330. doi: 10.3389/fonc.2020.520330.
   PubMed Web of Science ®Google Scholar
• Xia X, Cai Y, Cui X, et al. Temporal trend in mortality of cardiovascular diseases and its contribution to life expectancy increase in China, 2013 to 2018. Chin Med J. 2022;135(17):2066–2075. doi: 10.1097/CM9.0000000000002082.
   PubMed Web of Science ®Google Scholar
• Joint Task Force for Guideline on The A, Management of Cardiovascular Risk in C. Guideline on the assessment and management of cardiovascular risk in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53(1):13–35.
   PubMedGoogle Scholar
• Li W, Liu H, Qian W, et al. Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer. Comput Struct Biotechnol J. 2018;16:479–487. doi: 10.1016/j.csbj.2018.10.006.
   PubMed Web of Science ®Google Scholar
• Han L, Ma Q, Li J, et al. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS One. 2011;6(11):e27074. doi: 10.1371/journal.pone.0027074.
   PubMed Web of Science ®Google Scholar
• Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy. 2005;4(6):619–625. doi: 10.2174/156801005774912806.
   PubMedGoogle Scholar
• Newsholme P, Keane KN, Carlessi R, et al. Oxidative stress pathways in pancreatic β-cells and insulin-sensitive cells and tissues: importance to cell metabolism, function, and dysfunction. Am J Physiol Cell Physiol. 2019;317(3):C420–C433. doi: 10.1152/ajpcell.00141.2019.
   PubMed Web of Science ®Google Scholar
• Liakopoulos V, Roumeliotis S, Gorny X, et al. Oxidative stress in patients undergoing peritoneal dialysis: a current review of the literature. Oxid Med Cell Longev. 2017;2017:3494867. doi: 10.1155/2017/3494867.
   PubMed Web of Science ®Google Scholar
• Betjes MG, Meijers RW, Litjens NH. Loss of renal function causes premature aging of the immune system. Blood Purif. 2013;36(3–4):173–178. doi: 10.1159/000356084.
   PubMed Web of Science ®Google Scholar
• Stigant CE, Bargman JM. What’s new in peritoneal dialysis: biocompatibility and continuous flow peritoneal dialysis. Curr Opin Nephrol Hypertens. 2002;11(6):597–602. doi: 10.1097/00041552-200211000-00005.
   PubMed Web of Science ®Google Scholar
• Wieslander A, Linden T, Musi B, et al. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids. Perit Dial Int. 2000;20(5_suppl):23–27. doi: 10.1177/089686080002005S05.
   Google Scholar
• Siska PJ, Rathmell JC. T cell metabolic fitness in antitumor immunity. Trends Immunol. 2015;36(4):257–264. doi: 10.1016/j.it.2015.02.007.
   PubMed Web of Science ®Google Scholar
• Jacobs SR, Herman CE, Maciver NJ, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol. 2008;180(7):4476–4486. doi: 10.4049/jimmunol.180.7.4476.
   PubMed Web of Science ®Google Scholar
• Xiaoyan J, Rongyi C, Xuesen C, et al. The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality. BMC Nephrol. 2019;20(1):301. doi: 10.1186/s12882-019-1475-y.
   PubMed Web of Science ®Google Scholar
• Betjes MG, DE Wit EE, Weimar W, et al. Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol Dial Transplant. 2010;25(11):3640–3646. doi: 10.1093/ndt/gfq203.
   PubMed Web of Science ®Google Scholar
• Adair T, Lopez AD. The role of overweight and obesity in adverse cardiovascular disease mortality trends: an analysis of multiple cause of death data from Australia and the USA. BMC Med. 2020;18(1):199. doi: 10.1186/s12916-020-01666-y.
   PubMed Web of Science ®Google Scholar
• Ezzati M, Obermeyer Z, Tzoulaki I, et al. Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol. 2015;12(9):508–530. doi: 10.1038/nrcardio.2015.82.
   PubMed Web of Science ®Google Scholar
• Fortes PC, Versari PH, Stinghen AE, et al. Controlling inflammation in peritoneal dialysis: the role of pd-related factors as potential intervention targets. Perit Dial Int. 2007;27(Suppl 2):76–81.
   Google Scholar
• Wang AY. Consequences of chronic inflammation in peritoneal dialysis. Semin Nephrol. 2011;31(2):159–171. doi: 10.1016/j.semnephrol.2011.01.005.
   PubMed Web of Science ®Google Scholar
• Chen T, Hassan HC, Qian P, et al. High-Sensitivity troponin T and C-reactive protein have different prognostic values in Hemo- and peritoneal dialysis populations: a cohort study. J Am Heart Assoc. 2018;7(5):e007876.
   PubMed Web of Science ®Google Scholar
• Meuwese CL, Stenvinkel P, Dekker FW, et al. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011;7(3):166–176. doi: 10.1038/nrneph.2011.2.
   PubMed Web of Science ®Google Scholar
• Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19(1):217–224. doi: 10.1245/s10434-011-1814-0.
   PubMed Web of Science ®Google Scholar
• Eroglu A, Akbulut S. The role of pretreatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in the diagnosis of breast cancer: predicting lymph node metastasis. World J Oncol. 2013;4(6):262–263. doi: 10.4021/wjon744w.
   PubMedGoogle Scholar
• Chen S, Zhou S, Wu B, et al. Association between metabolically unhealthy overweight/obesity and chronic kidney disease: the role of inflammation. Diabetes Metab. 2014;40(6):423–430. doi: 10.1016/j.diabet.2014.08.005.
   PubMed Web of Science ®Google Scholar
• Zhang L, Nie Y, Guo M, et al. Neutrophil to lymphocyte ratio as a predictor of long-term outcome in peritoneal dialysis patients: a 5-Year cohort study. Blood Purif. 2021;50(6):772–778. doi: 10.1159/000510552.
   PubMed Web of Science ®Google Scholar
• Zhang F, Li L, Wu X, et al. Pan-immune-inflammation value is associated with poor prognosis in patients undergoing peritoneal dialysis. Ren Fail. 2023;45(1):2158103. doi: 10.1080/0886022X.2022.2158103.
   PubMed Web of Science ®Google Scholar